Antibacterial Activity of Surfactin and Synergistic Effect with Conventional Antibiotics Against Methicillin-Resistant Staphylococcus aureus Isolated from Patients with Diabetic Foot Ulcers

References

• Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018;35(1):78–88.
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Senneville E, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36 Suppl 1:e3280.
   PubMed Web of Science ®Google Scholar
• Złoch M, Maślak E, Kupczyk W, Jackowski M, Pomastowski P, Buszewski B. Culturomics Approach to Identify Diabetic Foot Infection Bacteria. Int J Mol Sci. 2021;22(17):566.
   PubMed Web of Science ®Google Scholar
• Macdonald KE, Boeckh S, Stacey HJ, Jones JD. The microbiology of diabetic foot infections: a meta-analysis. BMC Infect Dis. 2021;21(1):770.
   PubMed Web of Science ®Google Scholar
• Haaber J, Penades JR, Ingmer H. Transfer of Antibiotic Resistance in Staphylococcus aureus. Trends Microbiol. 2017;25(11):893–905.
   PubMed Web of Science ®Google Scholar
• Korting HC, Schollmann C, Stauss-Grabo M, Schafer-Korting M. Antimicrobial peptides and skin: a paradigm of translational medicine. Skin Pharmacol Physiol. 2012;25(6):323–334.
   PubMed Web of Science ®Google Scholar
• Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415(6870):389–395.
   PubMed Web of Science ®Google Scholar
• Ngambenjawong C, Chan LW, Fleming HE, Bhatia SN. Conditional Antimicrobial Peptide Therapeutics. ACS Nano. 2022;16(10):15779–15791.
   PubMed Web of Science ®Google Scholar
• Bonmatin JM, Laprevote O, Peypoux F. Diversity among microbial cyclic lipopeptides: iturins and surfactins. Activity-structure relationships to design new bioactive agents. Comb Chem High Throughput Screen. 2003;6(6):541–556.
   PubMed Web of Science ®Google Scholar
• Chen X, Lu Y, Shan M, Zhao H, Lu Z, Lu Y. A mini-review: mechanism of antimicrobial action and application of surfactin. World J Microbiol Biotechnol. 2022;38(8):143.
   PubMed Web of Science ®Google Scholar
• Munusamy S, Conde R, Bertrand B, Munoz-Garay C. Biophysical approaches for exploring lipopeptide-lipid interactions. Biochimie. 2020;170:173–202.
   PubMed Web of Science ®Google Scholar
• Penha RO, Vandenberghe LPS, Faulds C, Soccol VT, Soccol CR. Bacillus lipopeptides as powerful pest control agents for a more sustainable and healthy agriculture: recent studies and innovations. Planta. 2020;251(3):70.
   PubMed Web of Science ®Google Scholar
• Zeriouh H, de Vicente A, Perez-Garcia A, Romero D. Surfactin triggers biofilm formation of Bacillus subtilis in melon phylloplane and contributes to the biocontrol activity. Environ Microbiol. 2014;16(7):2196–2211.
   PubMed Web of Science ®Google Scholar
• Abdelli F, Jardak M, Elloumi J, et al. Antibacterial, anti-adherent and cytotoxic activities of surfactin(s) from a lipolytic strain Bacillus safensis F4. Biodegradation. 2019;30(4):287–300.
   PubMed Web of Science ®Google Scholar
• Zouari R, Moalla-Rekik D, Sahnoun Z, Rebai T, Ellouze-Chaabouni S, Ghribi-Aydi D. Evaluation of dermal wound healing and in vitro antioxidant efficiency of Bacillus subtilis SPB1 biosurfactant. Biomed Pharm. 2016;84:878–891.
   PubMed Web of Science ®Google Scholar
• Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163–175.
   PubMed Web of Science ®Google Scholar
• Li Z, Ding Z, Liu Y, et al. Phenotypic and Genotypic Characteristics of Biofilm Formation in Clinical Isolates of Acinetobacter baumannii. Infect Drug Resist. 2021;14:2613–2624.
   PubMed Web of Science ®Google Scholar
• Stepanović S, Vuković D, Dakić I, Savić B, Švabić-vlahović M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175–179.
   PubMed Web of Science ®Google Scholar
• Tan P, Lai Z, Jian Q, et al. Design of Heptad Repeat Amphiphiles Based on Database Filtering and Structure-Function Relationships to Combat Drug-Resistant Fungi and Biofilms. ACS Appl Mater Interfaces. 2020;12(2):2129–2144.
   PubMed Web of Science ®Google Scholar
• Doern CD. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J Clin Microbiol. 2014;52(12):4124–4128.
   PubMed Web of Science ®Google Scholar
• She P, Zhou L, Li S, et al. Synergistic Microbicidal Effect of Auranofin and Antibiotics Against Planktonic and Biofilm-Encased S. aureus. Front Microbiol. 2019;10:2453.
   PubMed Web of Science ®Google Scholar
• Firsov AA, Smirnova MV, Lubenko IY, Vostrov SN, Portnoy YA, Zinner SH. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model. J Antimicrob Chemother. 2006;58(6):1185–1192.
   PubMed Web of Science ®Google Scholar
• Zhao X, Drlica K. Restricting the Selection of Antibiotic‐Resistant Mutant Bacteria: measurement and Potential Use of the Mutant Selection Window. J Infect Dis. 2002;185(4):561–565.
   PubMed Web of Science ®Google Scholar
• Jiang L, Xie N, Chen M, et al. Synergistic Combination of Linezolid and Fosfomycin Closing Each Other’s Mutant Selection Window to Prevent Enterococcal Resistance. Front Microbiol. 2020;11:605962.
   PubMed Web of Science ®Google Scholar
• Li T, Li Z, Huang L, et al. Cigarette Smoking and Peripheral Vascular Disease are Associated with Increasing Risk of ESKAPE Pathogen Infection in Diabetic Foot Ulcers. Diabetes Metab Syndr Obes. 2022;15:3271–3283.
   PubMed Web of Science ®Google Scholar
• Pitocco D, Spanu T, Di Leo M, et al. Diabetic foot infections: a comprehensive overview. Eur Rev Med Pharmacol Sci. 2019;23(2 Suppl):26–37.
   PubMedGoogle Scholar
• Zubair M, Malik A, Ahmad J. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary care hospital. Foot. 2012;22(1):24–30.
   PubMedGoogle Scholar
• Liu J, Li W, Zhu X, et al. Surfactin effectively inhibits Staphylococcus aureus adhesion and biofilm formation on surfaces. Appl Microbiol Biotechnol. 2019;103(11):4565–4574.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Liu F, Zhang X, et al. Cellulose-dependent expression and antibacterial characteristics of surfactin from Bacillus subtilis HH2 isolated from the giant panda. PLoS One. 2018;13(1):e0191991.
   PubMed Web of Science ®Google Scholar
• Gu Y, Zheng R, Sun C. Isolation, Identification and Characterization of Two Kinds of Deep-Sea Bacterial Lipopeptides Against Foodborne Pathogens. Front Microbiol. 2022;13:792755.
   PubMed Web of Science ®Google Scholar
• Liston SD, Willis LM. Racing to build a wall: glycoconjugate assembly in Gram-positive and Gram-negative bacteria. Curr Opin Struct Biol. 2021;68:55–65.
   PubMed Web of Science ®Google Scholar
• Mileykovskaya E, Dowhan W. Visualization of Phospholipid Domains in Escherichia coli by Using the Cardiolipin-Specific Fluorescent Dye 10-N-Nonyl Acridine Orange. J Bacteriol. 2000;182(4):1172–1175.
   PubMed Web of Science ®Google Scholar
• Carrillo C, Teruel JA, Aranda FJ, Ortiz A. Molecular mechanism of membrane permeabilization by the peptide antibiotic surfactin. Biochim Biophys Acta. 2003;1611(1–2):91–97.
   PubMed Web of Science ®Google Scholar
• Pouget C, Dunyach-Remy C, Pantel A, Schuldiner S, Sotto A, Lavigne JP. Biofilms in Diabetic Foot Ulcers: significance and Clinical Relevance. Microorganisms. 2020;8(10):1580.
   PubMed Web of Science ®Google Scholar
• Malik A, Mohammad Z, Ahmad J. The diabetic foot infections: biofilms and antimicrobial resistance. Diabetes Metabolic Syndrome. 2013;7(2):101–107.
   PubMedGoogle Scholar
• Banu A, Noorul hassan MM, Rajkumar J, Srinivasa S. Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: a prospective study. Australas Med J. 2015;8(9):280–285.
   PubMedGoogle Scholar
• Schilcher K, Horswill AR. Staphylococcal Biofilm Development: structure, Regulation, and Treatment Strategies. Microbiol Mol Biol Rev. 2020;84(3):128.
   Web of Science ®Google Scholar
• Mottola C, Semedo-Lemsaddek T, Mendes JJ, et al. Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococci. J Biomed Sci. 2016;23:33.
   PubMed Web of Science ®Google Scholar
• Englerova K, Bedlovicova Z, Nemcova R, et al. Bacillus amyloliquefaciens-Derived Lipopeptide Biosurfactants Inhibit Biofilm Formation and Expression of Biofilm-Related Genes of Staphylococcus aureus. Antibiotics. 2021;10(10):1252.
   Google Scholar
• Thappeta KRV, Zhao LN, Nge CE, et al. In-Silico Identified New Natural Sortase A Inhibitors Disrupt S. aureus Biofilm Formation. Int J Mol Sci. 2020;21(22):56.
   Web of Science ®Google Scholar
• Oh KB, Oh MN, Kim JG, Shin DS, Shin J. Inhibition of sortase-mediated Staphylococcus aureus adhesion to fibronectin via fibronectin-binding protein by sortase inhibitors. Appl Microbiol Biotechnol. 2006;70(1):102–106.
   PubMed Web of Science ®Google Scholar
• Vestergaard M, Frees D, Ingmer H. Antibiotic Resistance and the MRSA Problem. Microbiol Spectrum. 2019;7(2):1252.
   Web of Science ®Google Scholar
• Cassone M, Otvos L Jr. Synergy among antibacterial peptides and between peptides and small-molecule antibiotics. Expert Rev Anti Infect Ther. 2010;8(6):703–716.
   PubMed Web of Science ®Google Scholar
• Ulvatne H, Karoliussen S, Stiberg T, Rekdal O, Svendsen JS. Short antibacterial peptides and erythromycin act synergically against Escherichia coli. J Antimicrob Chemother. 2001;48(2):203–208.
   PubMed Web of Science ®Google Scholar
• Cudic M, Condie BA, Weiner DJ, et al. Development of novel antibacterial peptides that kill resistant isolates. Peptides. 2002;23(12):2071–2083.
   PubMed Web of Science ®Google Scholar
• Cassone M, Vogiatzi P, La Montagna R, et al. Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics. Peptides. 2008;29(11):1878–1886.
   PubMed Web of Science ®Google Scholar